Recombinant Probable tautomerase spyM18_1099 (spyM18_1099)

What is the predicted structure and function of spyM18_1099 tautomerase?

Tautomerase spyM18_1099 is a predicted enzyme from Streptococcus pyogenes M18 strain that likely catalyzes tautomerization reactions, facilitating the conversion between tautomeric forms of substrates. Based on structural prediction methodologies similar to those used for other bacterial tautomerases, the protein likely contains conserved catalytic residues essential for tautomerase activity . Specifically, the N-terminal proline residue is typically crucial for catalysis in many tautomerases, serving as a catalytic base in the active site as observed in other bacterial tautomerases.

Structural analysis likely reveals a protein with distinct domains having differential conservation patterns. This organization may mirror findings in other bacterial proteins like PPE18, where the first domain is highly conserved while the second exhibits greater variability . Such architectural features often reflect the protein's essential functional role in bacterial physiology versus regions potentially involved in immune evasion or host interaction.

What expression systems are most effective for producing recombinant spyM18_1099?

For laboratory-scale production of recombinant spyM18_1099, E. coli expression systems typically yield optimal results. Using methodologies similar to those employed for other bacterial proteins, BL21(DE3) strains with pET-based vectors are recommended due to their tight regulation and high expression capabilities. The protein should be expressed with an N-terminal tag positioned to avoid interference with the catalytic N-terminal proline, which is critical for tautomerase activity.

Expression protocols should include optimization of:

For projects requiring mammalian post-translational modifications, systems such as HEK293 or CHO cells may be considered, though yields will likely be significantly lower compared to bacterial systems.

How can the enzymatic activity of recombinant spyM18_1099 be measured?

The tautomerase activity of spyM18_1099 can be measured using spectrophotometric assays similar to those employed for other tautomerases. The classic substrate 4-hydroxyphenylpyruvate (HPP) may be utilized, with activity monitored by measuring changes in absorbance at 300 nm as the enol form is converted to the keto form.

A standard enzymatic assay protocol includes:

• Prepare assay buffer (typically 50 mM sodium phosphate, pH 6.5)

• Add purified recombinant spyM18_1099 (0.1-10 μg/ml final concentration)

• Initiate reaction by adding substrate (0.1-1.0 mM HPP)

• Monitor absorbance change at 300 nm for 1-5 minutes

• Calculate enzyme activity using the molar extinction coefficient

Alternative substrates such as phenylpyruvate or p-hydroxyphenylpyruvate may also be tested to determine substrate specificity. Importantly, activity measurements should include controls with catalytically inactive mutants (such as P1G variants as described for MIF tautomerase) to confirm specificity of the observed activity.

How does site-directed mutagenesis of the N-terminal proline affect spyM18_1099 tautomerase activity?

Based on research approaches with similar tautomerases, site-directed mutagenesis of the N-terminal proline (P1) is expected to significantly impact the enzymatic activity of spyM18_1099. Following methodologies analogous to those used for MIF tautomerase, a P1G mutation (proline to glycine substitution) would likely abolish tautomerase activity while potentially preserving other functional aspects of the protein .

A comprehensive mutagenesis approach should include:

• Generation of mutants focusing on:

  • N-terminal proline (P1G, P1A, P1S)

  • Other predicted active site residues

  • Conserved residues identified through sequence alignment

• Expression and purification of wild-type and mutant proteins using identical protocols

• Comparative analysis of:

  • Enzymatic activity using standardized assays

  • Structural integrity via circular dichroism spectroscopy

  • Thermostability through differential scanning fluorimetry

This systematic mutagenesis approach would elucidate the catalytic mechanism and structure-function relationships of spyM18_1099, providing insights comparable to those obtained for other bacterial tautomerases.

What are the potential physiological substrates of spyM18_1099 in Streptococcus pyogenes?

Identifying the physiological substrates of spyM18_1099 requires a multifaceted research approach. While standard substrates like HPP or phenylpyruvate may demonstrate activity in vitro, they may not represent the actual substrates in the bacterial context.

A comprehensive substrate identification strategy should include:

• Metabolomic analysis comparing wild-type S. pyogenes with ΔspyM18_1099 knockout strains to identify accumulated metabolites in the absence of the enzyme

• In vitro screening of bacterial metabolites using purified recombinant spyM18_1099, focusing on:

  • Aromatic amino acid derivatives

  • Intermediates of secondary metabolite biosynthesis

  • Compounds involved in cell wall synthesis

• Isothermal titration calorimetry (ITC) to determine binding affinities for potential substrates

• Structural docking studies based on homology models to predict substrate binding

The integration of these approaches would provide insights into the physiological role of spyM18_1099 within the bacterial metabolism, potentially revealing novel functions beyond canonical tautomerase activity.

How does structural variation in spyM18_1099 across clinical Streptococcus pyogenes isolates affect function?

Similar to observations with PPE18 proteins in Mycobacterium tuberculosis , spyM18_1099 may exhibit sequence and structural variations across clinical isolates of S. pyogenes. To investigate this:

• Obtain spyM18_1099 sequences from diverse clinical isolates representing different:

  • Geographic regions

  • Disease manifestations

  • Emm types (M protein serotypes)

• Perform sequence analysis to:

  • Identify conserved vs. variable regions

  • Calculate Shannon's entropy at each residue position

  • Determine coevolutionary clusters of residues

• Generate homology models of variant proteins to predict structural changes

• Express and characterize select variants to determine functional implications of observed variations

How can researchers generate catalytically inactive spyM18_1099 for functional studies?

To generate catalytically inactive spyM18_1099 for functional studies while maintaining protein structure, the P1G mutation approach described for MIF tautomerase can be adapted . This requires:

• Site-directed mutagenesis of the N-terminal proline to glycine

• Verification of DNA sequence

• Expression and purification under identical conditions as wild-type

• Confirmation of:

  • Loss of enzymatic activity

  • Preservation of structural integrity through circular dichroism

  • Thermal stability profile similar to wild-type

This P1G mutant provides an essential research tool for distinguishing between enzymatic and non-enzymatic functions of spyM18_1099. For example, when investigating potential roles in host-pathogen interactions, the P1G mutant allows researchers to determine whether observed effects depend on catalytic activity or protein-protein interactions independent of enzymatic function .

What are the optimal conditions for crystallization of recombinant spyM18_1099?

Crystallization of recombinant spyM18_1099 requires systematic screening of conditions, focusing on parameters that have proven successful for other bacterial tautomerases:

• Protein preparation:

  • Highly purified protein (>95% purity by SDS-PAGE)

  • Concentration range: 5-15 mg/ml

  • Buffer exchange to remove imidazole and other additives

• Initial screening:

  • Commercial sparse matrix screens (Hampton Research, Molecular Dimensions)

  • Temperature variations (4°C and 20°C)

  • Sitting drop and hanging drop methods

• Optimization strategies:

  • Fine-tuning of promising conditions

  • Additive screening

  • Seeding techniques for crystal improvement

Successful crystallization would enable determination of the three-dimensional structure of spyM18_1099, providing insights into the catalytic mechanism and substrate binding pocket. This structural information would be invaluable for designing specific inhibitors and understanding the enzyme's physiological role.

How does spyM18_1099 potentially modulate host immune responses during infection?

Based on immunomodulatory properties observed with other bacterial tautomerases, spyM18_1099 may influence host immune responses during S. pyogenes infection. Investigation of this potential role requires:

• Cell-based assays examining:

  • Effects on macrophage polarization

  • Cytokine production profiles (TNF-α, IL-6, IL-10)

  • NF-κB pathway activation

• Comparative studies using:

  • Wild-type spyM18_1099

  • Catalytically inactive P1G mutant

  • Heat-denatured protein controls

• In vivo infection models comparing:

  • Wild-type S. pyogenes

  • Isogenic ΔspyM18_1099 knockout

  • Complemented strain expressing P1G mutant

Similar to findings with MIF tautomerase in metabolic inflammation , the enzymatic activity of spyM18_1099 may influence inflammatory processes during streptococcal infection. Understanding whether these effects depend on catalytic activity (using the P1G mutant as control) would provide insights into potential mechanisms of immune modulation.

What are the optimal purification strategies for recombinant spyM18_1099?

Purification of recombinant spyM18_1099 requires a tailored approach to obtain high-purity protein suitable for functional and structural studies:

• Initial capture:

  • Immobilized metal affinity chromatography (IMAC) for His-tagged protein

  • Buffer optimization to prevent precipitation (typically 50 mM Tris-HCl, pH 8.0, 300 mM NaCl)

• Secondary purification:

  • Size exclusion chromatography to remove aggregates

  • Ion exchange chromatography for removal of contaminating proteins

• Tag removal considerations:

  • Protease selection based on construct design

  • Optimization of cleavage conditions

  • Reverse IMAC to separate cleaved tag

Optimizing these purification parameters is essential for obtaining protein suitable for enzymatic assays, crystallization attempts, and functional studies.

How can researchers design experiments to assess the role of spyM18_1099 in Streptococcus pyogenes virulence?

Investigating the role of spyM18_1099 in S. pyogenes virulence requires a systematic experimental approach:

• Genetic manipulation strategies:

  • Construction of isogenic knockout mutant (ΔspyM18_1099)

  • Complementation with wild-type gene

  • Complementation with catalytically inactive P1G mutant

• In vitro virulence assays:

  • Biofilm formation capacity

  • Adherence to epithelial cells

  • Resistance to phagocytosis

  • Survival in human blood

• In vivo infection models:

  • Murine skin infection model

  • Invasive disease model

  • Pharyngeal colonization model

• Transcriptomic analysis:

  • RNA-seq comparing wild-type and ΔspyM18_1099

  • Identification of dysregulated virulence factors

  • Validation of key findings by qRT-PCR

This comprehensive approach would determine whether spyM18_1099 contributes to S. pyogenes virulence and whether any observed effects depend on its catalytic activity (by comparing complementation with wild-type versus P1G mutant).

What statistical approaches are most appropriate for analyzing enzyme kinetic data for spyM18_1099?

Proper statistical analysis of enzyme kinetic data for spyM18_1099 is essential for reliable interpretation of results:

• Experimental design considerations:

  • Minimum of three technical replicates per condition

  • Independent biological replicates (separate protein preparations)

  • Inclusion of appropriate controls (buffer, heat-inactivated enzyme)

• Kinetic parameter determination:

  • Non-linear regression for Michaelis-Menten kinetics

  • Lineweaver-Burk or Eadie-Hofstee plots as secondary visualization

  • Bootstrap methods for confidence interval estimation

• Statistical comparison between variants:

  • One-way ANOVA with appropriate post-hoc tests for multiple comparisons

  • Two-way ANOVA when examining effects of multiple factors

• Reporting requirements:

  • Km and Vmax values with confidence intervals

  • Goodness-of-fit metrics (R² values)

  • Explicit statement of replication level

Following these statistical approaches as outlined in established experimental design references ensures robust analysis of kinetic data, facilitating meaningful comparisons between wild-type spyM18_1099 and variants or between different experimental conditions.

How does pH affect the catalytic activity and stability of spyM18_1099?

The pH dependence of spyM18_1099 activity and stability provides insights into the catalytic mechanism and physiological function:

• pH-activity profile determination:

  • Measure enzymatic activity across pH range 4.0-9.0

  • Use overlapping buffer systems (acetate, MES, phosphate, Tris)

  • Determine pH optimum and shape of pH-activity curve

• pH stability assessment:

  • Pre-incubate enzyme at various pH values for defined periods

  • Measure residual activity under standard conditions

  • Determine pH range for stability

• Structural analysis:

  • Circular dichroism spectroscopy at various pH values

  • Intrinsic fluorescence measurements to detect conformational changes

  • Thermal denaturation profiles at different pH values

The resulting pH-activity and pH-stability profiles would inform about the catalytic mechanism, potentially identifying key ionizable residues involved in catalysis, similar to studies conducted with other bacterial tautomerases.

What bioinformatic approaches can identify potential epitopes in spyM18_1099 for immunological studies?

Comprehensive epitope prediction for spyM18_1099 requires integration of multiple bioinformatic approaches:

• T-cell epitope prediction:

  • Consensus algorithms from IEDB (similar to methods used for PPE18)

  • MHC class I and II binding prediction

  • Processing prediction (proteasomal cleavage, TAP transport)

• B-cell epitope prediction:

  • Surface accessibility calculation

  • Antigenicity prediction

  • Structural flexibility analysis

• Conservation analysis:

  • Calculate Shannon's entropy across variant sequences

  • Correlate epitope prediction with sequence conservation

  • Identify epitopes in conserved versus variable regions

• Structural mapping:

  • Project predicted epitopes onto 3D structural models

  • Analyze spatial clustering of epitopes

  • Evaluate accessibility in the folded protein

How can researchers investigate potential moonlighting functions of spyM18_1099 beyond its enzymatic activity?

Many bacterial enzymes possess moonlighting functions beyond their primary catalytic activity. To investigate such potential functions for spyM18_1099:

• Protein-protein interaction studies:

  • Pull-down assays with bacterial and host proteins

  • Yeast two-hybrid screening

  • Crosslinking mass spectrometry

• Binding assays with host factors:

  • ELISA-based binding to extracellular matrix components

  • Surface plasmon resonance with potential host receptors

  • Cellular binding and internalization studies

• Comparative functional analysis:

  • Wild-type spyM18_1099

  • Catalytically inactive P1G mutant

  • Structure-guided surface mutants

• Subcellular localization studies:

  • Immunofluorescence microscopy

  • Cell fractionation

  • Surface accessibility analysis

This comprehensive approach would determine whether spyM18_1099 possesses secondary functions independent of its tautomerase activity, potentially contributing to bacterial adaptation or host-pathogen interactions in ways not directly related to its enzymatic function.